WEN-CHI YANGFeng-Ming HsuPAN-CHYR YANG2020-12-022020-12-0220201021-7770https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088514500&doi=10.1186%2fs12929-020-00676-5&partnerID=40&md5=fbde20a3ff7269a348c7c440337b8f75https://scholars.lib.ntu.edu.tw/handle/123456789/523423Precision medicine is becoming the standard of care in anti-cancer treatment. The personalized precision management of cancer patients highly relies on the improvement of new technology in next generation sequencing and high-throughput big data processing for biological and radiographic information. Systemic precision cancer therapy has been developed for years. However, the role of precision medicine in radiotherapy has not yet been fully implemented. Emerging evidence has shown that precision radiotherapy for cancer patients is possible with recent advances in new radiotherapy technologies, panomics, radiomics and dosiomics. This review focused on the role of precision radiotherapy in non-small cell lung cancer and demonstrated the current landscape. ? 2020 The Author(s).[SDGs]SDG3proteome; biotechnology; cancer genetics; cancer patient; cancer radiotherapy; clinical outcome; disease marker; dosiomics; epigenetics; evidence based medicine; human; metabolome; non small cell lung cancer; nonhuman; omics; panomics; personalized medicine; positron emission tomography; priority journal; radiation dose; radiomics; radiotherapy technology; Review; single nucleotide polymorphism; tumor immunology; x-ray computed tomography; lung tumor; non small cell lung cancer; personalized medicine; procedures; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Precision Medicine; Radiotherapyreview10.1186/s12929-020-00676-5326937922-s2.0-85088514500